| Cancer Cell International | |
| Growth inhibitory and chemo-sensitization effects of naringenin, a natural flavanone purified from Thymus vulgaris, on human breast and colorectal cancer | |
| Raja’a J Al-Attiyah2  Ebtehal Al-Quattan3  Khaled Y Orabi1  Mohamed Salah I Abaza3  | |
| [1] Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kuwait University, Safat 13110, Kuwait;Department of Microbiology and Immunology, Faculty of Medicine, Kuwait University, Safat 13110, Kuwait;Molecular Biology Program, Department of Biological Sciences, Faculty of Science, Kuwait University, Safat 13060, Kuwait | |
| 关键词: Molecular mechanisms; Chemo-sensitization; Anticancer effects; Colorectal and breast cancers; Naringenin; | |
| Others : 1217736 DOI : 10.1186/s12935-015-0194-0 |
|
| received in 2014-06-29, accepted in 2015-04-06, 发布年份 2015 | |
PDF
|
|
【 摘 要 】
Background
Natural products with diverse bioactivities are becoming an important source of novel agents with medicinal potential. Cancer is a devastating disease that causes the death of millions of people each year. Thus, intense research has been conducted on several natural products to develop novel anticancer drugs.
Methods
Chromatographic and spectral techniques were used for the isolation and identification of naringenin (Nar). MTT, flow cytometry, western blotting, Real Time PCR were used to test anticancer and chemosensitizing effects of Nar, cell cycle, apoptosis, and expression of cell cycle, apoptosis, pro-survival and anti-survival-related genes.
Results
In the present study, Thymus vulgaris ethanol extract was purified repeatedly to produce several compounds including the known flavanone, Nar which was identified using different spectral techniques. Nar was shown to inhibit both human colorectal and breast cancer cell growth in a dose- and time-dependent manner through cell cycle arrest at S- and G2/M-phases accompanied by an increase in apoptotic cell death. Additionally, Nar altered the expression of apoptosis and cell-cycle regulatory genes by down-regulating Cdk4, Cdk6, Cdk7, Bcl2, x-IAP and c-IAP-2 and up-regulating p18, p19, p21, caspases 3, 7, 8 and 9, Bak, AIF and Bax in both colorectal and breast cancer cells. Conversely, it diminished the expression levels of the cell survival factors PI3K, pAkt, pIκBα and NFκBp65. Moreover, Nar enhanced the sensitivity of colorectal and breast cancer cells to DNA-acting drugs.
Discussion
These findings provide evidence that Nar’s pro-apoptotic and chemo-sensitizing effects are mediated by perturbation of cell cycle, upregulation of pro-apoptotic genes and down-regulation of anti-apoptotic genes and inhibition of pro-survival signaling pathways.
Conclusion
In conclusion, Nar might be a promising candidate for chemoprevention and/or chemotherapy of human cancers. However, further studies exploring this therapeutic strategy are necessary.
【 授权许可】
2015 Abaza et al.; licensee BioMed Central.
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| 20150708033102967.pdf | 3672KB | ||
| Figure 8. | 65KB | Image | |
| Figure 7. | 70KB | Image | |
| Figure 6. | 67KB | Image | |
| Figure 5. | 60KB | Image | |
| Figure 4. | 93KB | Image | |
| Figure 3. | 76KB | Image | |
| Figure 2. | 47KB | Image | |
| Figure 1. | 90KB | Image |
【 图 表 】
Figure 1.
Figure 2.
Figure 3.
Figure 4.
Figure 5.
Figure 6.
Figure 7.
Figure 8.
【 参考文献 】
- [1]The global burden of disease: 2004 update. World Health Organization, Geneva; 2008.
- [2]Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61:69-90.
- [3]El-Basmy A, Al-Mohannadi A, Al-Awadi A. Some epidemiological measures of cancer in Kuwait: national cancer registry data from 2000–2009. Asian Pac J Cancer Prev. 2012; 13:3113-8.
- [4]Carvalho M, Jeronimo C, Valentao P, Andrade PB, Silva BM. Green tea: a promising anticancer agent for renal cell carcinoma. Food Chem. 2010; 122:49-54.
- [5]Tan AC, Konczak I, Sze DM, Ramzan I. Molecular pathways for cancer chemoprevention by dietary phytochemicals. Nutr Cancer. 2012; 63:495-505.
- [6]Wahle KW, Brown I, Rotondo D, Heys SD. Plant phenolics in the prevention and treatment of cancer. Adv Exp Med Bio. 2011; 698:36-51.
- [7]Clere N, Faure S, Martinez MC, Andriantsitohaina R. Anticancer properties of flavonoids: role in various stages of carcinogenesis. Cardiovasc Hematol Agents Med Chem. 2011; 9:62-77.
- [8]Yoshida H, Takamura N, Shuto T, Orgata K, Tokunaga J, Kawa K et al.. The citrus flavonoids hesperetin and naringenin block the lipolytic actions of TNFα in mouse adipocytes. Biochem Biophs Res Commun. 2010; 2010:728-32.
- [9]Arul D, Subramanian P. Inhibitory effect of naringenin (citrus flavonone) on N-nitrosodiethylamine induced hepatocarcinogenesis in rats. Biochem Biophs Res Commun. 2013; 434:203-9.
- [10]Hendawy SF, Ezz El-din A, Aziz EE, Omer EA. Productivity and oil quality of Thymus vulgaris under organic fertilization condition. Ozean Journal of Applied Sciences. 2010; 3:203-16.
- [11]El-Nekeety AA, Mohamed SR, Hathout AS, Hassan NS, Aly SE, Abdel-Wahhab MS. Antioxidant properties of Thymus vulgaris oil against aflatoxin-induced oxidative stress in male rats. Toxicol. 2011; 57:984-91.
- [12]Stahl-Biskup E, Saez F. Thyme. Taylor and Francis, London; 2002.
- [13]Amirghofran A, Karimi MH. Cytotoxicity of Thymus vulgaris, Achillea millefolium and Thuja orientalis on growing cell lines. MJIRI. 2001; 15:149-54.
- [14]Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983; 65:55-63.
- [15]Abaza MSI, Bahman A, Al-Attiyah R. Valproic acid, an antiepileptic drug with histone deacetylase inhibition activity, and proteasome inhibitors exert synergistic antiproliferative, proapoptotic and chemosensitizing effects in human colorectal cancer cells: underlying molecular mechanisms. Int J Mol Med. 2014; 34:513-32.
- [16]Fan XM, Wong BC, Wang WP, Zhou XM, Cho CH, Yuen ST et al.. Inhibition of proteasome function induced apoptosis in gastric cancer. Int J Cancer. 2001; 93:481-8.
- [17]Abaza MSI. Augmentation of the anticancer effects of proteasome inhibitors by combination with sodium butyrate in human colorectal cancer cells. Exp Ther Med. 2010; 1:675-93.
- [18]Chen W, Li Z, Bai L, Lin Y. NFκB in lung cancer, a carcinogenesis mediator and a prevention and therapy target. Front Biosci. 2011; 16:1172-85.
- [19]Kulik G, Klippel A, Weber MJ. Antiapoptotic signaling by the insulin-like growth factor receptor, phosphatidylinositol 3-kinase, and Akt. Mol Cell Biol. 1997; 17:1595-606.
- [20]Malumbres M, Barbacid M. Mammalian cyclin-dependent kinases. Trends Biochem Sci. 2005; 30:630-41.
- [21]Borner C. The Bcl2 protein family; sensor and checkpoints for life-or-death decisions. Mol Immunol. 2003; 39:615-47.
- [22]Cragg GM, Newman DJ, Snader KM. Natural products in drug discovery and development. J Nat Prod. 1997; 60:52-60.
- [23]Kandaswami C, Lee MT. The antitumor activities of flavonoids. In Vivo. 2005; 19:895-909.
- [24]Jin CY, Park C, Hwang HJ, Kim GY, Choi BT, Kim WJ et al.. Naringenin up-regulates the expression of death receptor 5 and enhances TRAIL-induced apoptosis in human lung cancer A549 cells. Mol Nutr Food Res. 2010; 55:300-9.
- [25]Kanno S, Tomizawa A, Ohtake T, Koiwai K, Ujibe M, Ishikawa M. Naringenin-induced apoptosis via activation of NF-κB and necrosis involving the loss of ATP in human promyeloleukemia HL-60 cells. Toxicol Lett. 2006; 166:131-9.
- [26]Wang BD, Yang ZY, Wang Q, Cai TK, Crewdson P. Synthesis, characterization, cytotoxic activities, and DNA-binding properties of the La (III) complex with naringenin Schiff-base. Bioorg Med Chem. 2006; 14:1880-8.
- [27]Jain R, Mitta M. Naringenin, a flavanone from the stem of Nyctanthes Arbotristis Linn. International Journal of Biology, Pharmacy and Allied Sciences. 2012; 1:964-72.
- [28]Lee I, Bae J, Kim T, Kwon O, Kim TH. polyphenolic constituents from the aerial parts of Thymus quinquecosttus var. japonica collected on Ulleung Island. J Korean Soc Appl Biol Chem. 2011; 54:811-6.
- [29]Arul D, Subramanian P. Naringenin (citrus flavonone) induces growth inhibition, cell cycle arrest and apoptosis in human hepatocellular carcinoma cells. Pathol Oncol Res. 2013; 19:763-70.
- [30]Frydoonfar HR, McGrath DR, Spigelman AD. The variable effect on proliferation of a colon cancer cell line by the citrus fruit flavonoid naringenin. Colorectal Dis. 2003; 5:149-52.
- [31]Kim JH, Kang JW, Kim MS, Bak Y, Park YS, Jung KY et al.. The apoptotic effects of the flavonoids N101-2 in human cervical cancer cells. Toxicol in Vitro. 2012; 26:67-73.
- [32]Sulfikkarali N, Krishnakumar N, Manoharan S, Nirmal RM. Chemopreventive efficacy of naringenin-loaded nanoparticles in 7, 12-dimethylbenz (a) anthracene induced experimental oral carcinogenesis. Pathol Oncol Res. 2013; 19:287-96.
- [33]Krishnakumar N, Sulfikkarali N, Manoharan S, Nirmal RM. Screening of chemopreventive effect of naringenin-loaded nanoparticles in DMBA-induced hamster buccal pouch carcinogenesis by FT-IR spectroscopy. Mol Cell Biochem. 2013; 382:27-36.
- [34]Dickson MA, Schwartz GK. Development of cell cycle inhibitors for cancer therapy. Curr Oncol. 2009; 16:36-43.
- [35]Adhami VM, Aziz MH, Reagan-Shaw SR, Nihl M, Mukhtar H, Ahmad N. Sanguinarine causes cell cycle blockade and apoptosis of human prostate carcinoma cells via modulation of cyclin kinase inhibitor-cyclin-cyclin-dependent kinase machinery. Mol Cancer Ther. 2004; 3:933-40.
- [36]Kögel D, Fulda S, Mittelbronn M. Therapeutic exploitation of apoptosis and autophagy for glioblastoma. Anticancer Agents Med Chem. 2010; 10:438-49.
- [37]McConkey DJ. Therapy-induced apoptosis in primary tumors. Adv Exp Med Biol. 2007; 608:31-51.
- [38]Tan M, Zhu J, Pan Y, Chen Z, Liang H, Liu H et al.. Synthesis, cytotoxic activity, and DNA binding properties of copper (II) complexes with hesperetin, naringenin, and apigenin. Bioinorganic Chem Appl. 2009; 2009:347872-80.
- [39]Sabarinathan D, Mahalakshmi P, Vanisree AJ. Naringenin promote apoptosis in cerebrally implanted C6 glioma cells. Mol Cell Biochem. 2010; 345:215-22.
- [40]Zhong Z, Chen X, Tan W, Xu Z, Zhou K, Wu T et al.. Germacrone inhibits the proliferation of breast cancer cell by inducing cell cycle arrest and promoting apoptosis. Eur J Pharmacol. 2011; 667:50-5.
- [41]Park HS, Kim GY, Nam TJ, Deuk Kim N, Hyun Choi Y. Antiproliferative activity of fucoidan was associated with the induction of apoptosis and autophagy in AGS human gastric cells. J Food Sci. 2011; 26:77-83.
- [42]Bak Y, Kim H, Kang JW, Lee DH, Kim MS, Jung KY et al.. A synthetic naringenin derivative, 5-hydroxy-7, 4́-diacetyloxyflavanone-N-phenylhydrazone (N101-43), induces apoptosis through up-regulation of Fas/FasL expression and inhibition of PI3K/Akt signaling pathways in non-small-cell lung cancer cells. J Agric Food Chem. 2011; 59:10286-97.
- [43]Franke TF, Yang SL, Chan TO, Datta K, Kazlauskas A, Morrison DK et al.. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell. 1995; 81:727-36.
- [44]Park JH, Jin CY, Lee BK, Kim GY, Lee BK, Kim GY et al.. Naringenin induces apoptosis through downregulation of Akt and caspase-3 activation in human leukemia THP-1 cells. Food Chem Toxicol. 2008; 46:3684-90.
- [45]Datta SR, Brunet A, Greenberg ME. Cellular survival: a play in three Akts. Genes Dev. 1999; 13:2905-27.
- [46]Ciechomska I, Pyrzynska B, Razmierczak P, Kaminska B. Inhibition of Akt kinase signaling and activation of Forkhead are indispensable for upregulation of FasL expression in apoptosis of glioma cells. Oncogene. 2003; 22:7617-27.
- [47]Uriarte SM, Joshi-Barve S, Song Z, Sahoo R, Gobejishvili L. Akt inhibition up-regulates FasL, downregulates c-FLIPs and induces caspase-8-dependent cell death in Jurkat T lymphocytes. Cell Death Differ. 2005; 12:233-42.
- [48]Madrid LV, Mayo MW, Reuther JY, Baldwin AS. Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-κB through utilization of the I-κB kinase and activation of the mitogen-activated protein kinase p38. J Biol Chem. 2001; 276:18934-40.
- [49]Nakagawa Y, Sedukhina AS, Okamoto N, Nagasawa S, Suzuki N, Ohta T et al.. NF-κB signaling mediates acquired resistance after PARP inhibition. Advance Publications, Oncotarget; 2015.
- [50]Chu IM, Hengst L, Slingerland JM. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat Rev Cancer. 2008; 8:253-67.
- [51]Tanse S, Ikenishi A, Okayama H, Iwamoto N, Nakayama KI, Takeuchi T. CDK inhibitors, p21(Cip) and p27 (Kip1), participate in cell cycle exit of mammalian cardiomyocytes. Biochem Biophys Res Commun. 2014; 443:1105-9.
- [52]Tateishi Y, Matsumoto A, Kanie T, Hara E, Nakayama K, Nakayama KI. Development of mice without Cip/Kip CDK inhibitors. Biochem Biophys Res Commun. 2012; 427:285-92.
- [53]Yoon JH, Gores GJ. Death receptors-mediated apoptosis and the liver. J Hepatol. 2002; 37:400-10.
- [54]Mignotte B, Vayssiere JL. Mitochondria and apoptosis. Eur J Biochem. 1998; 252:1-15.
- [55]Sun SY, Hail N, Lotan R. Apoptosis as a novel target for cancer chemoprevention. J Natl Cancer Inst. 2004; 96:662-72.
- [56]Scaffidi C, Fulda S, Strinivasan A, Friesen C, Tomaselli KJ, Debatin KM et al.. Two CD95 (APO1/Fas) signaling pathways. EMBO Journal. 1998; 17:1675-87.
- [57]Tepper CG, Seldin MF, Mudryj M. Fas-mediated apoptosis of proliferating, transiently growth-arrested, and senescent normal human fibroblasts. Exp Cell Res. 2000; 260:9-19.
- [58]Hsu HF, Houng JY, Kuo CF, Tssao N, Wu YC. Glossogin, a novel phenylpropanoid from Glossogyne tenuifolia induced apoptosis in A549 lung cancer cells. Food Chem Toxicol. 2008; 46:3785-91.
- [59]Liu ZB, Hou YF, Min-Dong MD, Di GH, Wu J, Shen ZZ et al.. PA-MSHA inhibits proliferation and induces apoptosis through up-regulation and activation of caspases in the human breast cancer cell lines. J Cell Biochem. 2009; 108:195-206.
- [60]Li Y, Wang Y, Wang S, Gao Y, Zhang X, Lu C. Oridonin phosphate-induced autophagy effectively enhances cell apoptosis of human breast cancer cells. Med Oncol. 2015; 32:365.
- [61]Dlugosz PJ, Billen LP, Annis MG, Zhu W, Zhang Z, Lin J et al.. Bcl-2 changes conformation to inhibit Bax oligomerization. EMBO J. 2006; 25:2287-96.
- [62]Kelly PN, Strasser A. The role of Bcl-2 and its pro-survival relatives in tumorigenesis and cancer therapy. Cell Death Differ. 2011; 18:1414-24.
- [63]Martinou JC, Youle RJ. Mitochondria in apoptosis: Bcl-2 family members and mitochondria dynamics. Dev Cell. 2011; 21:92-101.
- [64]Hengartner MO. The Biochemistry of apoptosis. Nature. 2000; 407:770-8.
- [65]Oliver FJ, de La Rolli V, Ruiz-Ruiz MC, de Murcia G, Murcia JM. Importance of poly (ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant. J Biol Chem. 1998; 273:33533-9.
- [66]Wu PP, Kuo SC, Huang WW, Yang JS, Lai KC, Chen HJ et al.. (−)-epigallocatechin gallate induced apoptosis in human adrenal cancer NCI-H295 cells through caspase-dependent and caspase-independent pathway. Anticancer Res. 2009; 29:1435-42.
- [67]Schmidt M, Betti G, Hensel A. Saffron in phytotherapy: Pharmacology and clinical uses. Wiener Medizinische Wochenschrift. 2007; 157:315-9.
- [68]Wang QW, Lu HL, Song CC, Liu H, Xu CG. Radio-sensitivity of human colon cancer cell enhanced by immune-liposomal docetaxel. World J Gastroenterol. 2005; 14:4003-7.
- [69]Cost MIS, Boldrini JL. Conflicting objectives in chemotherapy with drug resistance. Bull Math Biol. 1997; 59:707-24.
- [70]Martin IC, Smith N, Cooper H. Deaths following chemotherapy-lesson to be learnt. Br J Oral Maxillofac Surg. 2009; 47:e51.
- [71]Towsley GL, Beck SL, Watkins JF. Learning to live with it: coping with the transition to cancer survivorship in older adults. Journal of Aging Studies. 2007; 21:93-106.
- [72]Zhang FY, Du GJ, Zhang L, Zhang CL, Lu WL, Liang W. Naringenin enhances the anti-tumor effect of doxorubicin through selectively inhibiting the activity of multidrug resistance-associated proteins but not P-glycoprotein. Pharm Res. 2009; 26:914-25.
- [73]Veeraraghavan S, Aravindan S, Natarajan M, Awasthi V, Herman S, Aravindan N. Neem leaf extract induces radio-sensitization in human neuroblastoma xenograft through modulation of apoptotic pathway. Anticancer Res. 2011; 31:161-70.
PDF